- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Reuters reported that Russia has decided to cut its stake in ALROSA (MCX:ALNU) via a share sale expected to be worth up to $1.8 billion. Fourteen percent of ALROSA’s shares will be sold by Russia’s federal and regional governments, while another 2 percent will be sold by a subsidiary of the company.
Reuters reported that Russia has decided to cut its stake in ALROSA (MCX:ALNU) via a share sale expected to be worth up to $1.8 billion. Fourteen percent of ALROSA’s shares will be sold by Russia’s federal and regional governments, while another 2 percent will be sold by a subsidiary of the company.
As quoted in the market news:
Alrosa is already listed on the Moscow stock exchange, with a free-float of around 9 percent. But only a small amount of those shares are actively traded and the market is illiquid.
That accounts for a market value of just over $8 billion, based on current trading, compared with the target valuation implied by the share sale, according to a banking source, of between $10 billion and $11 billion.
A separate source familiar with the deal said Alrosa was targeting a valuation of more than $10 billion. Alrosa declined to comment, though in May CEO Fyodor Andreev put the value at between $9 billion and $15 billion.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.